Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9)

Andrea Cortese, G. Vita, Marco Luigetti, M. Russo, Giulia Bisogni, M. Sabatelli, Fiore Manganelli, Lucio Santoro, Tiziana Cavallaro, G. M. Fabrizi, Angelo Schenone, M. Grandis, Chiara Gemelli, Alessandro Mauro, Luca Pradotto, Luca Gentile, Claudia Stancanelli, Alessandro Lozza, Stefano Perlini, Giuseppe PiscosquitoDaniela Calabrese, A. Mazzeo, Laura Piera Obici, Davide Pareyson

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)925-926
Number of pages2
JournalJournal of Neurology
Volume263
Issue number5
DOIs
Publication statusPublished - May 1 2016

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this

Cortese, A., Vita, G., Luigetti, M., Russo, M., Bisogni, G., Sabatelli, M., Manganelli, F., Santoro, L., Cavallaro, T., Fabrizi, G. M., Schenone, A., Grandis, M., Gemelli, C., Mauro, A., Pradotto, L., Gentile, L., Stancanelli, C., Lozza, A., Perlini, S., ... Pareyson, D. (2016). Erratum to: Monitoring effectiveness and safety of Tafamidis in transthyretin amyloidosis in Italy: a longitudinal multicenter study in a non-endemic area (Journal of Neurology, DOI: 10.1007/s00415-016-8064-9). Journal of Neurology, 263(5), 925-926. https://doi.org/10.1007/s00415-016-8116-1